Elsevier

The Lancet

Volume 318, Issue 8238, 18 July 1981, Pages 124-125
The Lancet

Preliminary Communications
DO THIAZIDES PREVENT RECURRENT IDIOPATHIC RENAL CALCIUM STONES?

https://doi.org/10.1016/S0140-6736(81)90302-0Get rights and content

Abstract

In a double-blind controlled clinical trial 62 patients with recurrent idiopathic renal calcium stone formation were allocated either to treatment with bendroflumethiazide, 2·5 mg three times a day, or placebo. In each group the rate of stone formation during medication (average follow-up period 18 months) was compared with the rate of stone formation before medication (average control period 36 months). In both groups a striking fall in the rate of stone formation to the same level was found, indicating that thiazides in this study did not alter the spontaneous course of idiopathic renal calcium stone formation. It is doubtful whether life-long prophylaxis with thiazide is justified in patients with moderate rate of stone formation.

References (7)

  • Er Yendt et al.

    Prevention of calcium stones with thiazides

    Kidney Int

    (1978)
  • U. Backmann et al.

    Effects of therapy with bendroflumethiazide in patients with recurrent renal calcium stones

    Br J Urol

    (1979)
  • Er Yendt et al.

    The use of thiazides in the prevention of renal calculi

    Can Med Ass J

    (1970)
There are more references available in the full text version of this article.

Cited by (0)

View full text